Raclopride
Raclopride is a synthetic compound known for its role as a selective antagonist at dopamine D2 and D3 receptors. It is used in scientific research to study the dopaminergic system, particularly in relation to Parkinson's disease, schizophrenia, and drug addiction.
Chemistry[edit]
Raclopride belongs to the chemical class of phenylpiperidines. It is a derivative of benzamide and is structurally related to other benzamide antipsychotics such as sulpiride and tiapride. The compound is chiral, and the form used in research is usually the more active (S)-(-)-enantiomer.
Pharmacology[edit]
Raclopride acts as a competitive antagonist at D2 and D3 dopamine receptors. This means it binds to these receptors without activating them, thereby blocking the effects of endogenous dopamine or other agonists. Raclopride has high affinity for D2 and D3 receptors and negligible affinity for other dopamine receptor subtypes.
Uses in Research[edit]
Raclopride is widely used in animal and human research to study the function of the dopaminergic system. It is commonly used in Positron Emission Tomography (PET) studies to measure dopamine receptor availability and the release of endogenous dopamine. In these studies, a radiolabelled form of raclopride is injected into the subject and its distribution in the brain is measured using PET imaging.
Clinical Significance[edit]
The ability of raclopride to block D2 and D3 receptors has made it a useful tool in the study of various neurological and psychiatric disorders. These include Parkinson's disease, where it has been used to investigate the role of dopamine in motor function, and schizophrenia, where it has been used to study the hypothesized overactivity of the dopaminergic system. Raclopride has also been used in research into drug addiction, to investigate the role of dopamine in reward and reinforcement.
See Also[edit]
 | This neuroscience article is a stub. You can help Wikipedia by adding missing information. |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
